Literature DB >> 29897819

Lesion of the OVLT markedly attenuates chronic DOCA-salt hypertension in rats.

John P Collister1, David B Nahey1, Rochelle Hartson1, Charles E Wiedmeyer2, Christopher T Banek3, John W Osborn3.   

Abstract

Lesions of the anteroventral third ventricle (AV3V region) are known to prevent many forms of experimental hypertension, including mineralocorticoid [deoxycorticosterone acetate (DOCA)-salt] hypertension in the rat. However, AV3V lesions include the organum vasculosum of the lamina terminalis (OVLT), portions of the median preoptic nucleus, and efferent fibers from the subfornical organ (SFO), thereby limiting the ability to define the individual contribution of these structures to the prevention of experimental hypertension. Having previously reported that the SFO does not play a significant role in the development of DOCA-salt hypertension, the present study was designed to test the hypothesis that the OVLT is necessary for DOCA-salt hypertension in the rat. In uninephrectomized OVLT-lesioned (OVLTx; n = 6) and sham-operated ( n = 4) Sprague-Dawley rats consuming a 0.1% NaCl diet and 0.9% NaCl drinking solution, 24-h mean arterial pressure (MAP) was recorded telemetrically 5 days before and 21 days after DOCA implantation (100 mg sc per rat). No differences in control MAP were observed between groups. The chronic pressor response to DOCA was attenuated in OVLTx rats such that MAP increased to 133 ± 3 mmHg in sham-operated rats by day 21 of DOCA compared with 120 ± 4 mmHg (means ± SE) in OVLTx rats. These results support the hypothesis that the OVLT is an important brain site of action for the pathogenesis of DOCA-salt hypertension in the rat.

Entities:  

Keywords:  DOCA-salt hypertension; myocardial infarction

Mesh:

Substances:

Year:  2018        PMID: 29897819      PMCID: PMC6172631          DOI: 10.1152/ajpregu.00433.2017

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  52 in total

1.  Multifactorial analysis of chronic hypertension induced by electrolyte-active steroids in trained, unanesthetized dogs.

Authors:  E L Bravo; R C Tarazi; H P Dustan
Journal:  Circ Res       Date:  1977-05       Impact factor: 17.367

Review 2.  Mechanisms of mineralocorticoid action.

Authors:  Peter J Fuller; Morag J Young
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

Review 3.  The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function.

Authors:  Gavin P Vinson
Journal:  J Endocrinol       Date:  2011-06-29       Impact factor: 4.286

4.  Effect of subfornical organ lesion on the development of mineralocorticoid-salt hypertension.

Authors:  John W Osborn; Frederic Jacob; Michael Hendel; John P Collister; Leah Clark; Pilar Ariza Guzman
Journal:  Brain Res       Date:  2006-07-21       Impact factor: 3.252

5.  Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.

Authors:  Christopher T Banek; Mark M Knuepfer; Jason D Foss; Jessica K Fiege; Ninitha Asirvatham-Jeyaraj; Dusty Van Helden; Yoji Shimizu; John W Osborn
Journal:  Hypertension       Date:  2016-10-03       Impact factor: 10.190

6.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

7.  Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

Review 8.  Central osmotic regulation of sympathetic nerve activity.

Authors:  G M Toney; Q H Chen; M J Cato; S D Stocker
Journal:  Acta Physiol Scand       Date:  2003-01

9.  Electrolyte and hormonal effects of deoxycorticosterone acetate in young pigs.

Authors:  R J Grekin; J M Terris; D F Bohr
Journal:  Hypertension       Date:  1980 May-Jun       Impact factor: 10.190

10.  OVLT lesion decreases basal arterial pressure and the chronic hypertensive response to AngII in rats on a high-salt diet.

Authors:  John P Collister; Marin K Olson; David B Nahey; Alexandre A Vieira; John W Osborn
Journal:  Physiol Rep       Date:  2013-10-23
View more
  6 in total

1.  Neuronal Networks in Hypertension: Recent Advances.

Authors:  Patrice G Guyenet; Ruth L Stornetta; George M P R Souza; Stephen B G Abbott; Virginia L Brooks
Journal:  Hypertension       Date:  2020-06-29       Impact factor: 10.190

Review 2.  Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.

Authors:  Leon J DeLalio; Alan F Sved; Sean D Stocker
Journal:  Can J Cardiol       Date:  2020-03-06       Impact factor: 5.223

3.  Activation of the Organum Vasculosum of the Lamina Terminalis Produces a Sympathetically Mediated Hypertension.

Authors:  Sean D Stocker; Megan M Wenner; William B Farquhar; Kirsteen N Browning
Journal:  Hypertension       Date:  2021-11-23       Impact factor: 10.190

Review 4.  Brain angiotensin converting enzyme-2 in central cardiovascular regulation.

Authors:  Mazher Mohammed; Clara Berdasco; Eric Lazartigues
Journal:  Clin Sci (Lond)       Date:  2020-10-16       Impact factor: 6.124

5.  Development of the Deoxycorticosterone Acetate (DOCA)-salt Hypertensive Rat Model.

Authors:  Nayara Pestana-Oliveira; David B Nahey; Tim Johnson; John P Collister
Journal:  Bio Protoc       Date:  2020-08-05

6.  Activation of Orexin 1 Receptors in the Paraventricular Nucleus Contributes to the Development of Deoxycorticosterone Acetate-Salt Hypertension Through Regulation of Vasopressin.

Authors:  Jeremy A Bigalke; Huanjia Gao; Qing-Hui Chen; Zhiying Shan
Journal:  Front Physiol       Date:  2021-02-03       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.